FDX2 and optic atrophy: Specific role(s) for FDX2 in these disorders remain uncertain, but 2 studies reported mitochondrial muscle myopathy with or without optic atrophy and reversible leukoencephalopathy (MEOAL; OMIM #251900) in patients with FDX2 mutations.